Imagine a lock that looks exactly like another lock from the outside…
but refuses every key that opens its twin.
For years, that's exactly what an immune receptor called C5aR2 has been to scientists around the world.
A mystery hiding in plain sight, inside your own body.
Until a team at IIT Kanpur cracked it open. 🔬
Your body has a built-in alarm system called the complement system.
When bacteria or viruses invade, it lights up inflammation and calls in defenders.
Two receptors sit at the heart of this alarm:
Nobody knew why.
For years, C5aR2 was the awkward cousin nobody could decode.
Professor Arun K. Shukla and his team used cryogenic-electron microscopy — the tech that lets you photograph proteins frozen in action.
And the answer was hiding inside the receptor.
👉 The outer shell of C5aR2 looks almost identical to C5aR1.
👉 But the inner machinery is built differently.
So when the usual signalling partners come knocking…
they simply can't dock.
C5aR2 was never broken. It was wired to a different switchboard all along.
Understanding the lock is one thing.
Building a key for it? That's where medicine gets made.
The team designed a brand-new molecule — R8Y — that does something remarkable:
That selectivity is the holy grail in drug design.
Because most drugs fail not because they're weak — but because they hit the wrong targets too.
The work was done at IIT Kanpur, in collaboration with The University of Queensland, University of Tokyo and Kyoto University.
Backed by DBT, Wellcome Trust India Alliance, ANRF, DST, ICMR and IIT Kanpur itself.
Next stop: animal trials.
C5aR2 is tangled up in sepsis, autoimmune disease, chronic inflammation — the messy conditions where today's drugs are blunt instruments.
A selective key like R8Y could mean cleaner therapies. Fewer side effects. Sharper aim.
A mystery that stumped global labs for years…
just got solved in Kanpur.
That's the India science story worth telling. 🇮🇳
That's all for now!
